Hiroaki Okamoto
5PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Apr 16, 2025
Pragmatic Randomized Study of Afatinib Versus Chemotherapy for Patients With Non-Small Cell Lung Cancer With Uncommon Epidermal Growth Factor Receptor Mutations: ACHILLES/TORG1834.Satoru Miura, Hiroshi Tanaka, Toshihiro Misumi
|Jan 02, 2024
Phase II Study of Durvalumab Immediately after Completion of Chemoradiotherapy in Unresectable Stage III Non-small Cell Lung Cancer: TORG1937 (DATE Study).Shinji Nakamichi, Kaoru Kubota, Toshihiro Misumi
|Sep 01, 2023
Five-Year Overall Survival Analysis of the JIPANG Study: Pemetrexed or Vinorelbine Plus Cisplatin for Resected Stage II-IIIA Nonsquamous Non-Small-Cell Lung Cancer.Hirotsugu Kenmotsu, Nobuyuki Yamamoto, Toshihiro Misumi
|Aug 14, 2023
Continuation of osimertinib in EGFR-mutant non-small-cell lung cancer patients bearing CNS metastasis (EPONA study).Yusuke Okuma, Shogo Nomura, Kiichiro Ninomiya
|Aug 18, 2022
A Randomized Comparison of Nivolumab versus Nivolumab + Docetaxel for Previously Treated Advanced or Recurrent ICI-Naïve Non-Small Cell Lung Cancer: TORG1630.Yuri Taniguchi, Tsuneo Shimokawa, Yuichi Takiguchi
Pageof 1
Frequent Collaborators
4 joint publications
Yuichi Takiguchi
3 joint publications
Toshihiro Misumi
3 joint publications
Naoki Furuya
3 joint publications
Yoshimasa Shiraishi
2 joint publications
Satoshi Ikeda
2 joint publications
Shuji Murakami
2 joint publications
Daijiro Harada
2 joint publications
Yasuhiro Goto
2 joint publications
Katsuhiko Naoki
2 joint publications
Satoru Miura
